Cargando…
Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications
Genetic variants have been reported to cause several genetic diseases. Various genotyping assays have been developed for diagnostic and screening purposes but with certain limitations in sensitivity, specificity, cost effectiveness and/or time savings. Since the discovery of ligase chain reaction (L...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108312/ https://www.ncbi.nlm.nih.gov/pubmed/28927538 http://dx.doi.org/10.1016/j.mrrev.2017.05.001 |
_version_ | 1783512786692734976 |
---|---|
author | Gibriel, Abdullah A. Adel, Ola |
author_facet | Gibriel, Abdullah A. Adel, Ola |
author_sort | Gibriel, Abdullah A. |
collection | PubMed |
description | Genetic variants have been reported to cause several genetic diseases. Various genotyping assays have been developed for diagnostic and screening purposes but with certain limitations in sensitivity, specificity, cost effectiveness and/or time savings. Since the discovery of ligase chain reaction (LCR) in the late nineties, it became one of the most favored platforms for detecting these variants and also for genotyping low abundant contaminants. Recent and powerful modifications with the integration of various detection strategies such as electrochemical and magnetic biosensors, nanoparticles (NPs), quantum dots, quartz crystal and leaky surface acoustic surface biosensors, DNAzyme, rolling circle amplification (RCA), strand displacement amplification (SDA), surface enhanced raman scattering (SERS), chemiluminescence and fluorescence resonance energy transfer have been introduced to both LCR and ligation based amplifications to enable high-throughput and inexpensive multiplex genotyping with improved robustness, simplicity, sensitivity and specificity. In this article, classical and up to date modifications in LCR and ligation based amplifications are critically evaluated and compared with emphasis on points of strength and weakness, sensitivity, cost, running time, equipment needed, applications and multiplexing potential. Versatile genotyping applications such as genetic diseases detection, bacterial and viral pathogens detection are also detailed. Ligation based gold NPs biosensor, ligation based RCA and ligation mediated SDA assays enhanced detection limit tremendously with a discrimination power approaching 1.5 aM, 2 aM and 0.1 fM respectively. MLPA (multiplexed ligation dependent probe amplification) and SNPlex assays have been commercialized for multiplex detection of at least 48 SNPs at a time. MOL-PCR (multiplex oligonucleotide ligation) has high-throughput capability with multiplex detection of 50 SNPs/well in a 96 well plate. Ligase detection reaction (LDR) is one of the most widely used LCR versions that have been successfully integrated with several detection strategies with improved sensitivity down to 0.4 fM. |
format | Online Article Text |
id | pubmed-7108312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71083122020-03-31 Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications Gibriel, Abdullah A. Adel, Ola Mutat Res Rev Mutat Res Article Genetic variants have been reported to cause several genetic diseases. Various genotyping assays have been developed for diagnostic and screening purposes but with certain limitations in sensitivity, specificity, cost effectiveness and/or time savings. Since the discovery of ligase chain reaction (LCR) in the late nineties, it became one of the most favored platforms for detecting these variants and also for genotyping low abundant contaminants. Recent and powerful modifications with the integration of various detection strategies such as electrochemical and magnetic biosensors, nanoparticles (NPs), quantum dots, quartz crystal and leaky surface acoustic surface biosensors, DNAzyme, rolling circle amplification (RCA), strand displacement amplification (SDA), surface enhanced raman scattering (SERS), chemiluminescence and fluorescence resonance energy transfer have been introduced to both LCR and ligation based amplifications to enable high-throughput and inexpensive multiplex genotyping with improved robustness, simplicity, sensitivity and specificity. In this article, classical and up to date modifications in LCR and ligation based amplifications are critically evaluated and compared with emphasis on points of strength and weakness, sensitivity, cost, running time, equipment needed, applications and multiplexing potential. Versatile genotyping applications such as genetic diseases detection, bacterial and viral pathogens detection are also detailed. Ligation based gold NPs biosensor, ligation based RCA and ligation mediated SDA assays enhanced detection limit tremendously with a discrimination power approaching 1.5 aM, 2 aM and 0.1 fM respectively. MLPA (multiplexed ligation dependent probe amplification) and SNPlex assays have been commercialized for multiplex detection of at least 48 SNPs at a time. MOL-PCR (multiplex oligonucleotide ligation) has high-throughput capability with multiplex detection of 50 SNPs/well in a 96 well plate. Ligase detection reaction (LDR) is one of the most widely used LCR versions that have been successfully integrated with several detection strategies with improved sensitivity down to 0.4 fM. Elsevier B.V. 2017-07 2017-05-02 /pmc/articles/PMC7108312/ /pubmed/28927538 http://dx.doi.org/10.1016/j.mrrev.2017.05.001 Text en © 2017 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Gibriel, Abdullah A. Adel, Ola Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications |
title | Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications |
title_full | Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications |
title_fullStr | Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications |
title_full_unstemmed | Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications |
title_short | Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications |
title_sort | advances in ligase chain reaction and ligation-based amplifications for genotyping assays: detection and applications |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108312/ https://www.ncbi.nlm.nih.gov/pubmed/28927538 http://dx.doi.org/10.1016/j.mrrev.2017.05.001 |
work_keys_str_mv | AT gibrielabdullaha advancesinligasechainreactionandligationbasedamplificationsforgenotypingassaysdetectionandapplications AT adelola advancesinligasechainreactionandligationbasedamplificationsforgenotypingassaysdetectionandapplications |